Physician profile
Michele Lowe
NPI 1841235884
$2,264.38
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,396 · 2020: $95.47 · 2022: $428 · 2023: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,043.13 | 2019-2022 | |
| Abbvie INC. | $260.97 | 2019-2023 | |
| Hologic Sales and Service, LLC | $233.75 | 2019-2023 | Myosure Tissue Removal Device |
| Astellas Pharma US INC | $120.54 | 2019-2023 | Myrbetriq, Veozah |
| Applied Medical Resources Corporation | $77.02 | 2022 | |
| Minerva Surgical, INC | $72.81 | 2019 | |
| Amgen INC. | $68.94 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.36 | 2019-2023 | |
| Pfizer INC. | $55.70 | 2022-2023 | |
| Therapeuticsmd, INC. | $45.62 | 2019 | |
| Myovant Sciences INC. | $39.24 | 2022 | |
| Baxter Healthcare | $37.29 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $26.30 | 2023 | Myfembree |
| Exeltis, USA INC. | $19.68 | 2022 | |
| Sage Therapeutics, LLC | $18.81 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.50 | 2022 | |
| Axonics, INC. | $16.13 | 2022 | |
| Urovant Sciences INC | $15.42 | 2022 | |
| Allergan, INC. | $14.18 | 2019 | |
| Duchesnay USA Incorporated | $12.22 | 2019 | |
| Meditrina | $6.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.